Anika Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Anika Therapeutics

07/05/2021 24:17

* Anika Therapeutics Inc  ANIK.OQ  reported quarterly adjusted
earnings of 20 cents​​ per share for the quarter ended in March.
The mean expectation of two analysts for the quarter was for a
loss of 12 cents per share.
* Revenue fell 3.1% to $34.29 million from a year ago​; 
analysts expected $32.20 million.
* Anika Therapeutics Inc's reported EPS for the quarter was 20
cents​.
* The mean earnings estimate of analysts had fallen by
about 516.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Anika Therapeutics Inc shares had risen by 1.6% this
quarter and lost 8.5% so far this year.
* The company reported quarterly net income of $2.84 million.
* Wall Street's median 12-month price target for Anika
Therapeutics Inc is $48.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 6 at 11:17 p.m. GMT. ​All
figures in US Dollars.​